Delivery Order SPE2DB20D3505-SPE2DB25FU3V4
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.88, is a delivery order for the medical product "ADBRY 300 MG/2 ML AUTOINJECTOR 2ML". The contract has an ultimate completion date of April 10, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,150.03, is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price delivery order. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $5,716.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product, with a completion date of February 19, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,757.64, is for the delivery of the pharmaceutical product ADBRY 150 MG/ML SYRINGE. The contract has an ultimate completion date of June 4, 2024 and is a Firm Fixed Price Delivery Order. There was no set-aside used for this award. Amerisourcebergen Drug Corp is the prime...
This federal contract award, valued at $5,617.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADBRY 150 MG/ML syringes and has an ultimate completion date of August 7, 2023. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $17,904.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of March 18, 2025. The contract provides for the delivery of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,297.57 fixed-price delivery order contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with a completion date of May 22, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, valued at $2,041.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and is a Firm Fixed Price contract. The award was not designated with a set-aside requirement, indicating open competition....
This federal contract award for $5,364.44 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product "ADBRY 150 MG/ML SYRINGEML" with a completion date of May 23, 2024. The contract is a firm fixed price award with no set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $21,247.90 firm fixed-price delivery order covers the supply of the pharmaceutical product ADBRY 150 MG/ML SYRINGEML. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a comprehensive procurement vehicle for a wide range...